ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 21 filers reported holding ELIEM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,586,733 | -6.1% | 13,150,849 | 0.0% | 0.68% | -2.0% |
Q2 2023 | $36,822,377 | -3.4% | 13,150,849 | 0.0% | 0.70% | -19.5% |
Q1 2023 | $38,137,462 | -21.0% | 13,150,849 | 0.0% | 0.86% | -11.8% |
Q4 2022 | $48,263,616 | +13.6% | 13,150,849 | 0.0% | 0.98% | +8.1% |
Q3 2022 | $42,477,000 | +7.0% | 13,150,849 | 0.0% | 0.91% | -14.4% |
Q2 2022 | $39,716,000 | -64.0% | 13,150,849 | 0.0% | 1.06% | -56.0% |
Q1 2022 | $110,336,000 | -19.8% | 13,150,849 | 0.0% | 2.41% | -0.7% |
Q4 2021 | $137,558,000 | -41.8% | 13,150,849 | 0.0% | 2.42% | -26.0% |
Q3 2021 | $236,452,000 | – | 13,150,849 | – | 3.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
Atom Investors LP | 78,886 | $207,470 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |